Please select the option that best describes you:
Topics:
Internal Medicine • Thrombosis • Hematology • Benign Hematology • Cardiology • Peripheral Vascular Disease
Are there data to support full-dose anticoagulation added to an antiplatelet in recurrent peripheral arterial thrombosis requiring revascularization and stenting?
Assume the patient does not have another indication for AC like VTE or AFib. Could this be suggestive of a hypercoagulable state?
Answer from: at Community Practice
I am not aware of any data for full dose anticoagulation, only lower dose anticoagulation which was the subject of the VOYAGER PAD study that did show reduced MALE rates when low dose Xarelto was added to either ASA or Plavix.
Sign in or Register to read more
Answer from: Medical Oncologist at Community Practice
This question comes up frequently at our institution. I previously consulted with our vascular surgery team who referred me to this trial of Edoxaban with SAPT, trying to avert what may be limb loss if the bypass graft/stent fails. We've often promoted rivaroxaban 2.5 mg po BID per VOYAGER PAD if we...